Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. scores highest on Nitro (81) and lowest on Price (7). Its PosiPenta is 48.33 out of 100, around the middle of similar companies.
On the Penta Grid this week, Edgewise Therapeutics, Inc. is Grid #310 of 837 in the Healthcare sector in United States, and Grid #2,077 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Edgewise Therapeutics, Inc. | 48.33 | 7 | 30 | 81 | 66 | 58 |
| Integer Holdings Corporation | 66.39 | 42 | 82 | 100 | 52 | 56 |
| Dianthus Therapeutics, Inc. | 46.55 | 19 | 18 | 66 | 72 | 57 |
| ICU Medical, Inc. | 62.73 | 33 | 91 | 83 | 52 | 55 |
| Indivior Pharmaceuticals, Inc. | 68.09 | 39 | 79 | 74 | 98 | 51 |
| Arcutis Biotherapeutics, Inc. | 57.65 | 7 | 87 | 90 | 58 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -19.99 |
| P/B ratio | 9.01 |
EEarnings
| Trailing EPS | ₹-176.17 |
| Forward EPS | ₹-168.02 |
NNitro
| Price | 3522.45 |
| 52-week high | 4594.62 |
| 52-week low | 1389.94 |
| Fall from 52-week high | 23.3% |
TTorque
| Return on equity (ROE) | -38.03% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 0.35 |
| Market cap | ₹38,255 Cr |
| Insider holding | 0.49% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Edgewise Therapeutics, Inc.'s PosiPenta score?
Edgewise Therapeutics, Inc.'s PosiPenta is 48.33 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Edgewise Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Edgewise Therapeutics, Inc. is Grid #310 of 837 in the Healthcare sector in United States, and Grid #2,077 of 4,000 in United States.
Which PosiPenta pillar is strongest for Edgewise Therapeutics, Inc.?
Nitro (momentum), with a score of 81 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Edgewise Therapeutics, Inc.?
Price (valuation), with a score of 7 out of 100: much weaker than most similar companies.
Has Edgewise Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.03 points, from 45.30 to 48.33.
PositoAI is for research and education only and is not investment advice.